We are live on ! Find out more
PBLA

Panbela Therapeutics, Inc. Common Stock
PBLA

Delisted

PBLA was delisted on the 6th of March, 2024.

Back to rankings

5 hedge funds and large institutions have $71.8K invested in Panbela Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 6 → 5 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

92% less capital invested

Capital invested by funds: $945K → $71.8K (-$873K)

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$60.2K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$26.6K
3
TRCT
Tower Research Capital (TRC)
New York
+$2.89K
4
Wells Fargo
Wells Fargo
California
+$34

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$542K
2
Walleye Capital
Walleye Capital
New York
-$217K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$175K
4
UBS Group
UBS Group
Switzerland
-$1.89K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$44.8K +$60.2K +1,793 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$19.9K +$26.6K +794 New
TRCT
3
Tower Research Capital (TRC)
New York
$7.13K +$2.89K +86 +46%
Wells Fargo
4
Wells Fargo
California
$29 +$34 +1 New
Morgan Stanley
5
Morgan Stanley
New York
$13 – – –
Bank of America
6
Bank of America
North Carolina
$3 – – –
Osaic Holdings
7
Osaic Holdings
Arizona
$2 – – –
SM
8
Sabby Management
Florida
– -$542K -11,791 Closed
Walleye Capital
9
Walleye Capital
New York
– -$217K -4,727 Closed
Hudson Bay Capital Management
10
Hudson Bay Capital Management
Connecticut
– -$175K -3,800 Closed
UBS Group
11
UBS Group
Switzerland
– -$1.89K -41 Closed

PBLA Hedge Fund Activity: Q3 2023 in Review

5 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Panbela Therapeutics, Inc. Common Stock (PBLA) for Q3 2023, worth a combined $71.8K — down 92% from $945K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PBLA and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $60.2K. The largest seller was Sabby Management, exiting entirely with an estimated $542K sold.

  • 5 institutional investors held Panbela Therapeutics, Inc. Common Stock (PBLA) as of Q3 2023, down from 6 in Q2 2023.
  • Funds reported $71.8K of Panbela Therapeutics, Inc. Common Stock stock for Q3 2023, down 92% quarter-over-quarter.
  • 3 funds opened new Panbela Therapeutics, Inc. Common Stock positions in Q3 2023 and 4 closed out, a net change of -1 holder.
  • The largest Panbela Therapeutics, Inc. Common Stock buyer in Q3 2023 was Citadel Advisors, an estimated $60.2K added.
  • The largest Panbela Therapeutics, Inc. Common Stock seller in Q3 2023 was Sabby Management, an estimated $542K sold.

Based on aggregated 13F filings for Q3 2023.